Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
‘It’s a No-Brainer,’ Says Daniel Ives About Palantir Stock
Palantir (NASDAQ:PLTR) stock hardly needed a push given the surge it has been on over the past year (up 508%) but it got one anyway earlier
Palantir Stock Soars 27% To All-Time High—Becoming $200 Billion Company
The AI-focused Palantir joins a group of less than 50 public American companies worth at least $200 billion, quite the turn of events for the government contractor worth less than $20 billion two years ago.
Palantir Stock Soars After Earnings Show Robust AI Demand
Palantir Technologies reported strong revenue growth last quarter as the company that made its name providing software to the U.S. government said demand for its artificial intelligence products continues to expand.
Buying Palantir Stock Today Is Like Buying Tesla Stock 10 Years Ago, Dan Ives Says: 'This Could Be A $1 Trillion Market Cap'
Wedbush's Dan Ives believes buying Palantir Technologies Inc (NYSE:PLTR) stock right now could be like buying Tesla Inc (NASDAQ:TSLA) stock in 2015.
‘Make an Exception,’ Says Top Investor About Palantir Stock
The momentum we are seeing across sectors, both commercial and government, is unlike anything that has come before,” declared Palantir
Palantir Stock Is Up 500% in the Past 12 Months. How Much Higher Can It Go?
On rare occasions, our expert team of analysts issues a “Double Down” stock recommendation for companies that they think are about to pop. If you’re worried you’ve already missed your chance to invest,
Palantir Shows the AI Trade Is Alive and Well. 2 Stocks That Could Benefit.
Palantir executives welcomed the advent of low-cost artificial intelligence. Other software stocks could also see benefits from cheaper AI.
10h
on MSN
Palantir stock is on a wild hot streak. Here's why so few analysts are bullish.
Palantir stock is trading at a lofty valuation "which history suggests is nearly impossible to grow into," Deutsche Bank's ...
24/7 Wall St. on MSN
4h
Buy, Sell, or Hold Palantir Stock at Over $100?
Palantir Technologies (NYSE:PLTR) has been a lightning rod for investor debate over the past few quarters as the stock has ...
5h
Palantir Stock: Too Hot To Touch (Rating Downgrade)
Despite impressive profitability and sales growth, PLTR's stock valuation at 53.5x leading sales is frothy, necessitating a ...
3h
Citigroup Slaps ‘Neutral’ Rating on Palantir (PLTR) Stock After Blowout Earnings
Palantir Technologies (PLTR) blowout financial results weren’t enough to convince analysts at Citigroup (C) that the stock is ...
47m
on MSN
Palantir Technologies Inc. (PLTR) Gets Street-High $125 Target After Q4 Beat, BofA Sees AI Revolution Ahead
We recently compiled a list of the 12 High Flying AI Stocks This Week. In this article, we are going to take a look at where ...
1d
on MSN
Prediction: This Artificial Intelligence (AI) Stock Could Leave Palantir in the Dust in 2025
Palantir ( PLTR 21.86%) has been a popular artificial intelligence (AI) stock pick over the past year. It surged by about 340 ...
10h
on MSN
DeepSeek Is Great, Say Google, Palantir, Nvidia. Why Stock Markets Should Worry and 5 Other Things to Know Today.
Alphabet revenue misses expectations, Robinhood Markets says Super Bowl bets are off, and more news to start your day.
2d
on MSN
Palantir’s stock surges as AI traction drives huge earnings beats across the board
Palantir bet on software that allows companies to deploy large-language models in a practical sense, and management says that ...
4h
Palantir CEO Says the Company Is a ‘Software Juggernaut.’ This Analyst is Unmoved.
A Citi Research analyst raised his price target on Palantir Technologies stock but is hesitant to rate it at Buy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Ai
Artificial intelligence
United States
PLTR
Merck & Co.
Feedback